MedVax Technologies, Inc. Announced Today Robert Brooks, CEO, Will Attend the 3rd Annual Sachs Cancer BioPartnering and Investment Forum
MIAMI, FL - May 23, 2015 - MedVax Technologies, Inc. CEO, Robert Brooks, will attend the 3rd Annual Sachs Cancer Bio Partnering & Investment Conference to be held February 23, 2015 at the New York Academy of Sciences in New York City.
The conference attracts leaders from cancer institutes, biotech, and pharma to efficiently and expeditiously promote partnering and investment opportunities. Hundreds of delegates will converge in New York City for this forum to listen to presentations from leading minds in cancer research. The keynote speeches and panels will cover topics including Gene and Cell Therapy, Next Gen Immunotherapeutics, and Personalized Medicine and Diagnostics.
About MedVax Technologies, Inc.
MedVax is a biopharmaceutical company discovering and commercializing cancer vaccines. MedVax's portfolio includes an autologous Adenovirus P53 dendritic cell vaccine in two FDA Phase II clinical trials, in Small Cell Lung Cancer, and Breast Cancer. MedVax also has a chimeric HER2 Peptide vaccine that is concluding a 2nd Phase I trial, and preparing for a phase II trial. Our team is comprised of experienced research scientists and business professionals with successful track records in the biotech industry.
About Sachs Associates Ltd.
Sachs Associates Ltd. is London-based and produces emerging markets and securities conferences in collaboration with major news agencies and exchanges. Sachs Associates Ltd. is dedicated to the highest quality standards in conferencing. Sachs Associates Ltd. investment forums facilitate business partnerships and transactions. Sachs Associates Ltd. sponsors maximum coverage in niche markets using targeted electronic and print media. The conferences are held in the world's largest financial centres including London, Zurich and New York.
VP, Business Administration & Public Relations
One Mifflin Place, Suite 400
Cambridge, MA 02138
Tel: (617) 674-7718
Fax: (617) 674-7701
25 SE 2nd Avenue, Suite 504
Miami, FL 33131
Tel: (305) 371-2301
Fax: (305) 371-2304
Source: MedVax Technologies, Inc.